Home › Therapeutic areas › Metabolic › Hypoparathyroidism
Hypoparathyroidism (2 companies)
Companies with an active program in Hypoparathyroidism.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ENTX | Entera Bio | GI/HepatologyMetabolic Rare | 1 | Phase 2 | $547M | 4 |
| SEPN | Septerna | ImmunologyMetabolic+1 Rare | 1 | Phase 1 | $2.28B | 5 |
No companies match.